🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well trabedersen (OT-101) in combination with...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-01
Trial ID
NCT05935774
This is a study of OT-101, a TGF-b2 inhibitor in combination of pembrolizum...
Status
Not Yet Recruiting
Location
University of Pennsylvania
Start Date
2025-06
Trial ID
NCT05425576
Treatments Being Tested
Primary Objective is to evaluate the safety and efficacy of OT-101+Artemisi...
Status
Unknown
Location
Praxis Pesquisa Medica S / S Ltda
Start Date
2021-04
Trial ID
NCT04801017
Treatments Being Tested
The goal of this clinical study is to compare the efficacy and safety of OT...
Status
Recruiting
Location
Karmanos Cancer Center
Start Date
2024-05-01
Trial ID
NCT06079346
Treatments Being Tested
The goal of this clinical trial is to: 1) evaluate the safety and recommend...
Status
Recruiting
Location
University of Nebraska Medical Center
Start Date
2025-05-12
Trial ID
NCT06579196
Treatments Being Tested
This is a phase III, randomized, double-masked, placebo-controlled, paralle...
Status
Active Not Recruiting
Location
Colorado Vision Institute
Start Date
2021-04-01
Trial ID
NCT04770610
Treatments Being Tested